|

Therapeutic Autologous Dendritic Cells Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Mayo Clinic1

Indications

  • Liver Disease1
  • Unresectable Intrahepatic Cholangiocarcinoma1
  • Stage IV Intrahepatic Cholangiocarcinoma AJCC v81
  • Stage III Intrahepatic Cholangiocarcinoma AJCC v81
  • Stage IV Hepatocellular Carcinoma AJCC v81

Rochester, Minnesota1 trial

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

Mayo Clinic in Rochester

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.